Cartesian Therapeutics, Inc. (RNAC)
10.17
+0.13
(+1.29%)
USD |
NASDAQ |
Aug 24, 16:00
10.17
0.00 (0.00%)
After-Hours: 20:00
Cartesian Therapeutics Total Liabilities (Quarterly) : 443.85M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 443.85M |
| March 31, 2026 | 436.51M |
| December 31, 2025 | 422.65M |
| September 30, 2025 | 408.52M |
| June 30, 2025 | 391.42M |
| March 31, 2025 | 430.92M |
| September 30, 2024 | 454.56M |
| June 30, 2024 | 449.20M |
| March 31, 2024 | 442.01M |
| December 31, 2023 | 444.68M |
| September 30, 2023 | 45.70M |
| June 30, 2023 | 74.06M |
| March 31, 2023 | 81.11M |
| December 31, 2022 | 72.06M |
| September 30, 2022 | 93.36M |
| June 30, 2022 | 98.46M |
| March 31, 2022 | 89.93M |
| December 31, 2021 | 137.36M |
| September 30, 2021 | 185.89M |
| June 30, 2021 | 184.74M |
| March 31, 2021 | 196.32M |
| Date | Value |
|---|---|
| December 31, 2020 | 183.44M |
| September 30, 2020 | 188.38M |
| June 30, 2020 | 88.26M |
| March 31, 2020 | 97.56M |
| December 31, 2019 | 91.17M |
| September 30, 2019 | 44.46M |
| June 30, 2019 | 46.89M |
| March 31, 2019 | 47.66M |
| December 31, 2018 | 49.90M |
| September 30, 2018 | 50.32M |
| June 30, 2018 | 49.18M |
| March 31, 2018 | 48.36M |
| December 31, 2017 | 49.29M |
| September 30, 2017 | 44.65M |
| June 30, 2017 | 38.84M |
| March 31, 2017 | 32.77M |
| December 31, 2016 | 34.34M |
| September 30, 2016 | 20.34M |
| June 30, 2016 | 22.54M |
| March 31, 2016 | 20.69M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Allogene Therapeutics, Inc. | 113.92M |
| Beam Therapeutics, Inc. | 318.91M |
| C4 Therapeutics, Inc. | 112.14M |
| Kyverna Therapeutics, Inc. | 54.27M |
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 318.63M |
| Shareholders Equity (Quarterly) | -125.23M |
| Debt to Equity Ratio | -0.5099 |
| Current Ratio | 7.475 |
| Net Debt Paydown Yield | -3.18% |